WO2018198101A3 - Processes for the preparation of crystalline form of eluxadoline - Google Patents
Processes for the preparation of crystalline form of eluxadoline Download PDFInfo
- Publication number
- WO2018198101A3 WO2018198101A3 PCT/IB2018/053134 IB2018053134W WO2018198101A3 WO 2018198101 A3 WO2018198101 A3 WO 2018198101A3 IB 2018053134 W IB2018053134 W IB 2018053134W WO 2018198101 A3 WO2018198101 A3 WO 2018198101A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- eluxadoline
- processes
- preparation
- crystalline form
- relates
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
The present invention relates to processes for the preparation of a crystalline form of eluxadoline.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201711014592 | 2017-04-25 | ||
| IN201711014592 | 2017-04-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2018198101A2 WO2018198101A2 (en) | 2018-11-01 |
| WO2018198101A3 true WO2018198101A3 (en) | 2019-05-16 |
Family
ID=63920194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IB2018/053134 Ceased WO2018198101A2 (en) | 2017-04-25 | 2018-05-04 | Processes for the preparation of crystalline form of eluxadoline |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2018198101A2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017015606A1 (en) | 2015-07-23 | 2017-01-26 | Teva Pharmaceuticals International Gmbh | Solid state forms of eluxadoline |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009009480A2 (en) * | 2007-07-09 | 2009-01-15 | Janssen Pharmaceutica N.V. | Novel crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy- benzoic acid |
| WO2017015606A1 (en) * | 2015-07-23 | 2017-01-26 | Teva Pharmaceuticals International Gmbh | Solid state forms of eluxadoline |
| WO2017153471A1 (en) * | 2016-03-11 | 2017-09-14 | Euticals S.P.A. | New stable solvate crystalline forms of eluxadolina |
| WO2017221213A1 (en) * | 2016-06-23 | 2017-12-28 | Sun Pharmaceutical Industries Limited | Processes for the preparation of eluxadoline |
| US20180029994A1 (en) * | 2015-02-23 | 2018-02-01 | Allergan Holdings Unlimited Company | Process for the preparation of intermediates useful in the synthesis of eluxadoline |
| WO2018046028A1 (en) * | 2016-09-07 | 2018-03-15 | Zentiva, K.S. | Solid forms of eluxadoline |
-
2018
- 2018-05-04 WO PCT/IB2018/053134 patent/WO2018198101A2/en not_active Ceased
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009009480A2 (en) * | 2007-07-09 | 2009-01-15 | Janssen Pharmaceutica N.V. | Novel crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy- benzoic acid |
| US20140011851A1 (en) * | 2007-07-09 | 2014-01-09 | Furiex Pharmaceuticals, Inc. | Novel crystals and process of making 5-(-METHYL)-2-METHOXY-BENZOIC ACID |
| US20180029994A1 (en) * | 2015-02-23 | 2018-02-01 | Allergan Holdings Unlimited Company | Process for the preparation of intermediates useful in the synthesis of eluxadoline |
| WO2017015606A1 (en) * | 2015-07-23 | 2017-01-26 | Teva Pharmaceuticals International Gmbh | Solid state forms of eluxadoline |
| WO2017153471A1 (en) * | 2016-03-11 | 2017-09-14 | Euticals S.P.A. | New stable solvate crystalline forms of eluxadolina |
| WO2017221213A1 (en) * | 2016-06-23 | 2017-12-28 | Sun Pharmaceutical Industries Limited | Processes for the preparation of eluxadoline |
| WO2018046028A1 (en) * | 2016-09-07 | 2018-03-15 | Zentiva, K.S. | Solid forms of eluxadoline |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018198101A2 (en) | 2018-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2015110897A3 (en) | Novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof | |
| WO2015195656A3 (en) | Synthesis of polycyclic-carbamoylpyridone compounds | |
| WO2016079751A3 (en) | A process for preparation of vortioxetine and polymorphs thereof | |
| WO2016071435A3 (en) | Synthesis of copanlisib and its dihydrochloride salt | |
| WO2018029711A3 (en) | Process for the preparation of venetoclax | |
| WO2015191945A3 (en) | Solid state forms of sofosbuvir | |
| WO2016125191A3 (en) | Processes for the preparation of vortioxetine hydrobromide | |
| WO2016009401A3 (en) | Preparation of tedizolid phosphate | |
| EP3694499A4 (en) | Novel process for the preparation of lifitegrast | |
| WO2018069941A3 (en) | Polymorphic forms of venetoclax | |
| HK1246299A1 (en) | Process of making cenicriviroc and related analogs | |
| WO2017168447A9 (en) | A cyclic compounds and process for the preparation thereof | |
| WO2016108206A3 (en) | Processes for preparation of idelalisib and intermediates thereof | |
| WO2016071362A3 (en) | Herbicidal compounds | |
| WO2015158769A8 (en) | Multichamber bag opening aid | |
| WO2016088081A8 (en) | Processes for the preparation of ertugliflozin | |
| WO2015181802A3 (en) | Oral pharmaceutical composition of isotretinoin | |
| WO2016181204A8 (en) | Method of making a mercury based compound, mercury based compound, methods of using the mercury based compound and uses of the mercury based compound | |
| WO2017098533A3 (en) | Process for preparation of lisdexamphetamine | |
| WO2018198101A3 (en) | Processes for the preparation of crystalline form of eluxadoline | |
| EP4403223A3 (en) | Crystal forms | |
| WO2016125185A3 (en) | Process for the preparation of 4-substituted-1-(trifluoromethoxy)benzene compounds | |
| WO2014195977A3 (en) | Novel polymorphs of vismodegib | |
| WO2016047924A3 (en) | Fluorescent-labeled novel dieckol derivative | |
| WO2017098520A8 (en) | Process for the preparation of labetalol hydrochloride |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18791521 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 18791521 Country of ref document: EP Kind code of ref document: A2 |